Exosome Diagnostic and Therapeutics Market: Germany, UK and France to Remain at the Forefront of Demand in the Western Europe Regional Market: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)
- REP-GB-6379
- 2018-02-20
- Category: Healthcare, Pharmaceuticals and Medical devices
- 225 Pages
- Format:
Key Findings
Top Five Players Account For Over 35% Share of the Exosome Diagnostics and Therapeutics Market
The exosome diagnostics and therapeutics market remains a fragmented landscape. Top five companies collectively represent a significant share in the exosome diagnostics and therapeutics market. These companies include Thermo Fisher Inc., Malvern Instruments, Miltenyi Biotec, Exosome Sciences and Exosome Diagnostics that account for over 35 percent revenue share in exosome diagnostics and therapeutics market.
Market presence of these tier 1 companies is mainly in the United States. Key participants in the exosome diagnostics and therapeutics market are mainly involved in new product launches and acquisitions. In 2017, Exosome Diagnostics launched MedOncAlyzer 170, its biopsy pan-cancer panel that circulates tumor DNA in a single assay. In addition, these players are also involved in collaborations and partnerships with local vendors in a bid to enhance their distribution network.
Favorable Support from Regulatory Bodies to Accelerate Growth
Increasing support from governments and regulatory bodies with respect to funding and research grants continues to influence the growth of exosome diagnostics and therapeutics market. Formulation of policies and subsidy provisions by various governments have encouraged research and development activities in the exosome diagnostics and therapeutics space.
Regulatory bodies have been encouraging development or up gradation of therapeutic devices for efficient treatment of chronic diseases. For instance, Food and Drug Administration (FDA) launched Breakthrough Devices Program in December 2017 to facilitate effective diagnosis of life-threatening diseases. Companies in the exosome diagnostics and therapeutics space are benefitted as they are able to enhance their therapeutic base. Aethlon Medical Inc., under the Breakthrough Devices Program, obtained EAP (Expedited Access Pathway) to push its Hemopurifier system as an effective treatment against fatal viruses.
Exosome Diagnostics and Therapeutics in Drug Delivery to Fight Chronic Conditions
Exosome diagnostics and therapeutics market is largely influenced by the growing potential of exosomes as carriers of functional RNA and proteins. The demand for exosome diagnostics and therapeutics is expected to increase at a significant pace owing to their use in drug delivery field. Several exosome agents are in pipeline that are being evaluated for chronic diseases. For instance, Capricor Therapeutics is assessing exosomes produced by CDCs for treating inflammatory conditions.
In addition, exosome diagnostics and therapeutics companies are focused on tapping exosome diagnostics and therapeutics potential to reduce metastasis. For instance, Aethlon Medical is developing HER2osome device. Use of exosome diagnostics and therapeutics as a potential agent in drug delivery is expected to fuel the growth of exosome diagnostics and therapeutics market in the coming years.
Venture Financing – New Trend in the Exosome Diagnostics and Therapeutics Market
Venture capital firms are investing in the exosome diagnostics and therapeutics market. Growing investments in the exosome diagnostics and therapeutics space are supporting upcoming start-ups in developing their exosome diagnostics and therapeutics platforms. For instance, Google Ventures supported a funding of US$ 45.4 million for exosome diagnostics and therapeutics company – Evox Therapeutics. This trend is likely to offer potential avenues for exosome diagnostics and therapeutics companies in turn supporting the future of exosome diagnostics and therapeutics as a major biotech breakthrough.
Competitive Landscape
Companies involved in the exosome diagnostics and therapeutics market are focusing on launching new exosome diagnostics and therapeutics products. For instance, Exosome Diagnostics Inc., has introduced bladder cancer surveillance panel, an addition in its exosome diagnostics and therapeutics portfolio.
Companies are launching tools and making investments to support exosome diagnostics and therapeutics research. Lonza has carried out huge investments via the acquisition of HansaBiomed Life Sciences in May 2017. Exosome diagnostics and therapeutics companies are also rolling out on conducting new clinical trials by achieving regulatory approvals. For instance, in December 2017, Capricor Therapeutics Inc., achieved clearance from FDA for new clinical trial of CAP-1002. Likewise, in 2018, Aegle gained clearance for its exosome diagnostics and therapeutics clinical trials in humans.
Companies are also involved in acquisitions to enhance their footprint in exosome diagnostics and therapeutics space. For instance, recently, Bio-Techne Corporation acquired Exosome Diagnostics to enhance its leadership in the exosome diagnostics and therapeutics market, particularly in on-invasive liquid biopsy space.
The insightful research report on global exosome diagnostic and therapeutics market provides a comprehensive analysis on every facet of the market along with forecasts. This research report will give the reader an explicit understanding of the global market with which informed decisions can be chalked to stay in pace with the changing market scenario. It will introduce a broad spectrum of several aspects involved along with forecasts thus supporting to detect major revenue pockets.
Portraying a global perspective
The research report on global exosome diagnostic and therapeutics market provides an exhaustive analysis on market shares, demand and supply analysis, sales volume and value analysis of various companies along with segmental analysis, with respect to important geographies of North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA) along with a regional breakdown. These regions are analysed keeping in view several aspects which influence the growth of the global exosome diagnostic and therapeutics market. The report contains an outline of forces which affect the global market scenario. This gives an idea of how to plan market entry strategies, establish connect with the various customers as well as target audience and to establish hold in that area. An unbiased holistic 3600 view of the global exosome diagnostic and therapeutics market is portrayed in the research report which supports the reader in making informed decisions based on strong data analysis and key recommendations.
Understanding the competition
The research report on global exosome diagnostic and therapeutics market covers product portfolios, pipeline analysis of key companies, for instance as big as Thermo Fisher Scientific, their strategies to maintain their present scenario in the market, their global presence and future expansion plans, mergers and acquisitions, distribution channel analysis, pricing analysis, product positioning tactics, etc. An entire section is dedicated to competitive landscape which includes information on the major key players in the global exosome diagnostic and therapeutics market both from the manufacturing side as well as the demand side.
A one-of-its-kind research methodology
A more robust, unique and effective research methodology has been followed by Future Market Insights in crafting the global exosome diagnostic and therapeutics market study which enables a near 100 percent accuracy in all angles. The research process uses primary research, secondary research and expert opinions to get a thorough understanding of the global market. Secondary research is the base of market understanding which is used to obtain a broad view of the market, basis which primary interviews are conducted during which data gleaning starts. Expert opinions are also tabulated and the data is cross verified. Each data point is cross checked and re-evaluated as the primary interview progresses. This enables the analysts to carry out data crunching with optimum accuracy. With this study it is possible to obtain actionable intelligence which delivers value addition to the reader.
Market Segmentation
|
By Product Type |
By Application |
By End User |
By Region |
|---|---|---|---|
|
|
|
|
How does this research report add value?
Future Market Insights extends support to organizations by doing all the research weight lifting and coordinating with their research teams to assist them in their tasks and achieve their goals and objectives. Below mentioned are few highlights which would entice you
-
An unbiased third party opinion is what the research promotes
-
Actionable intelligence which accompanies at every step
-
24x7 analyst support to resolve queries or attend any requirement pertaining to respective market along with respective domain experts
-
A near to 100 percent accuracy in data and statistics
-
In-depth weighted analysis with a deep dive in the market across several regions with a detailed five level segmentation
-
Analytically strong ten year forecasts to assist in planning future moves
-
Covers market controlling aspects, key developments and innovations from strategic and technological standpoints respectively
Exosome Diagnostic And Therapeutics Market Reports - Table of Contents
1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Global Economic Outlook
3. Exosome Diagnostic and Therapeutic Market View Point Analysis
3.1. Macro-Economic Factors
3.2. Drivers
3.3. Restraints
3.4. Opportunity Analysis
3.5. Trends
4. North America Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.2.1. U.S.
4.2.2. Canada
4.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.3.1. U.S.
4.3.2. Canada
4.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2016
4.4.1. Instrument
4.4.2. Software
4.4.3. Reagent
4.5. Market Size (US$ Mn) Forecast By Product, 2017–2027
4.5.1. Instrument
4.5.2. Software
4.5.3. Reagent
4.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
4.6.1. Diagnostic
4.6.2. Therapeutic
4.7. Market Size (US$ Mn) Forecast By Application, 2017–2027
4.7.1. Diagnostic
4.7.2. Therapeutic
4.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.8.1. Hospitals
4.8.2. Cancer Institutes
4.8.3. Diagnostic Centers
4.8.4. Others
4.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
4.9.1. Hospitals
4.9.2. Cancer Institutes
4.9.3. Diagnostic Centers
4.9.4. Others
4.10.Drivers and Restraints: Impact Analysis
4.11.Market Attractiveness Analysis
4.11.1. By Country
4.11.2. By Product
4.11.3. By Application
4.11.4. By End User
5. Latin America Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.2.1. Brazil
5.2.2. Mexico
5.2.3. Rest of Latin America
5.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2016
5.4.1. Instrument
5.4.2. Software
5.4.3. Reagent
5.5. Market Size (US$ Mn) and Volume Forecast By Product , 2017–2027
5.5.1. Instrument
5.5.2. Software
5.5.3. Reagent
5.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
5.6.1. Diagnostic
5.6.2. Therapeutic
5.7. Market Size (US$ Mn) Forecast By Application, 2017–2027
5.7.1. Diagnostic
5.7.2. Therapeutic
5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.8.1. Hospitals
5.8.2. Cancer Institutes
5.8.3. Diagnostic Centers
5.8.4. Others
5.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
5.9.1. Hospitals
5.9.2. Cancer Institutes
5.9.3. Diagnostic Centers
5.9.4. Others
5.10.Drivers and Restraints: Impact Analysis
5.11.Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Product
5.11.3. By Application
5.11.4. By End User
6. Western Europe Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.2.1. Germany
6.2.2. Italy
6.2.3. France
6.2.4. Spain
6.2.5. U.K.
6.2.6. Rest of Western Europe
6.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.3.1. Germany
6.3.2. Italy
6.3.3. France
6.3.4. Spain
6.3.5. U.K.
6.3.6. Rest of Western Europe
6.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2016
6.4.1. Instrument
6.4.2. Software
6.4.3. Reagent
6.5. Market Size (US$ Mn) Forecast By Product, 2017–2027
6.5.1. Instrument
6.5.2. Software
6.5.3. Reagent
6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
6.6.1. Diagnostic
6.6.2. Therapeutic
6.7. Market Size (US$ Mn) Forecast By Application, 2017–2027
6.7.1. Diagnostic
6.7.2. Therapeutic
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.8.1. Hospitals
6.8.2. Cancer Institutes
6.8.3. Diagnostic Centers
6.8.4. Others
6.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.9.1. Hospitals
6.9.2. Cancer Institutes
6.9.3. Diagnostic Centers
6.9.4. Others
6.10.Drivers and Restraints: Impact Analysis
6.11.Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Product
6.11.3. By Application
6.11.4. By End User
7. Eastern Europe Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.2.1. Russia
7.2.2. Poland
7.2.3. Rest of Eastern Europe
7.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2016
7.4.1. Instrument
7.4.2. Software
7.4.3. Reagent
7.5. Market Size (US$ Mn) Forecast By Product, 2017–2027
7.5.1. Instrument
7.5.2. Software
7.5.3. Reagent
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
7.6.1. Diagnostic
7.6.2. Therapeutic
7.7. Market Size (US$ Mn) Forecast By Application, 2017–2027
7.7.1. Diagnostic
7.7.2. Therapeutic
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.8.1. Hospitals
7.8.2. Cancer Institutes
7.8.3. Diagnostic Centers
7.8.4. Others
7.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.9.1. Hospitals
7.9.2. Cancer Institutes
7.9.3. Diagnostic Centers
7.9.4. Others
7.10.Drivers and Restraints: Impact Analysis
7.11.Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Product
7.11.3. By Application
7.11.4. By End User
8. Asia Pacific excluding Japan Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.2.1. China
8.2.2. India
8.2.3. Australia and New Zealand
8.2.4. Rest of APEJ
8.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. Rest of APEJ
8.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2016
8.4.1. Instrument
8.4.2. Software
8.4.3. Reagent
8.5. Market Size (US$ Mn) Forecast By Product, 2017–2027
8.5.1. Instrument
8.5.2. Software
8.5.3. Reagent
8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
8.6.1. Diagnostic
8.6.2. Therapeutic
8.7. Market Size (US$ Mn) Forecast By Application, 2017–2027
8.7.1. Diagnostic
8.7.2. Therapeutic
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.8.1. Hospitals
8.8.2. Cancer Institutes
8.8.3. Diagnostic Centers
8.8.4. Others
8.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.9.1. Hospitals
8.9.2. Cancer Institutes
8.9.3. Diagnostic Centers
8.9.4. Others
8.10.Drivers and Restraints: Impact Analysis
8.11.Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Product
8.11.3. By Application
8.11.4. By End User
9. Japan Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Product, 2012–2016
9.2.1. Instrument
9.2.2. Software
9.2.3. Reagent
9.3. Market Size (US$ Mn) Forecast By Product, 2017–2027
9.3.1. Instrument
9.3.2. Software
9.3.3. Reagent
9.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
9.4.1. Diagnostic
9.4.2. Therapeutic
9.5. Market Size (US$ Mn) Forecast By Application, 2017–2027
9.5.1. Diagnostic
9.5.2. Therapeutic
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
9.6.1. Hospitals
9.6.2. Cancer Institutes
9.6.3. Diagnostic Centers
9.6.4. Others
9.7. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.7.1. Hospitals
9.7.2. Cancer Institutes
9.7.3. Diagnostic Centers
9.7.4. Others
9.8. Drivers and Restraints: Impact Analysis
9.9. Market Attractiveness Analysis
9.9.1. By Product
9.9.2. By Application
9.9.3. By End User
10. Middle East & Africa Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
10.1.Introduction
10.2.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of MEA
10.3.Market Size (US$ Mn) Forecast By Country, 2017–2027
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
10.4.Historical Market Size (US$ Mn) Analysis By Product, 2012–2016
10.4.1. Instrument
10.4.2. Software
10.4.3. Reagent
10.5.Market Size (US$ Mn) Forecast By Product, 2017–2027
10.5.1. Instrument
10.5.2. Software
10.5.3. Reagent
10.6.Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
10.6.1. Diagnostic
10.6.2. Therapeutic
10.7.Market Size (US$ Mn) Forecast By Application, 2017–2027
10.7.1. Diagnostic
10.7.2. Therapeutic
10.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
10.8.1. Hospitals
10.8.2. Cancer Institutes
10.8.3. Diagnostic Centers
10.8.4. Others
10.9.Market Size (US$ Mn) Forecast By End User, 2017–2027
10.9.1. Hospitals
10.9.2. Cancer Institutes
10.9.3. Diagnostic Centers
10.9.4. Others
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Product
10.11.3. By Application
10.11.4. By End User
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1.Competition Dashboard
13.2.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
13.2.1. Thermo Fisher Scientific, Inc.
13.2.2. NanoSomix, Inc.
13.2.3. NX PHARMAGEN
13.2.4. Malvern Instruments Ltd
13.2.5. Capricor Therapeutics, Inc.
13.2.6. Exosome Diagnostics, Inc.
13.2.7. Exiqon A/S (Aethlon Medical, Inc.)
13.2.8. System Biosciences, Inc.
13.2.9. Aegle Therapeutics
13.2.10. AMS Biotechnology (Europe) Limited
13.2.11. Miltenyi Biotec
14. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027, By Region
14.1.Introduction/Key Findings
14.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Asia Pacific excluding Japan
14.2.6. Japan
14.2.7. Middle East & Africa
14.3.Market Size (US$ Mn) Forecast By Region, 2017–2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Asia Pacific excluding Japan
14.3.6. Japan
14.3.7. Middle East & Africa
14.4.Market Attractiveness Analysis By Region
15. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027, By Product
15.1.Introduction/Key Findings
15.2.Historical Market Size (US$ Mn) and Volume Analysis By Product , 2012–2016
15.2.1. Instrument
15.2.2. Software
15.2.3. Reagent
15.3.Market Size (US$ Mn) Forecast By Product, 2017–2027
15.3.1. Instrument
15.3.2. Software
15.3.3. Reagent
15.4.Market Attractiveness Analysis By Product
16. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027, By Application
16.1.Introduction/Key Findings
16.2.Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
16.2.1. Diagnostic
16.2.2. Therapeutic
16.3.Market Size (US$ Mn) Forecast By Application, 2017–2027
16.3.1. Diagnostic
16.3.2. Therapeutic
16.4.Market Attractiveness Analysis By Application
17. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027, By End User
17.1.Introduction/Key Findings
17.2.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
17.2.1. Hospitals
17.2.2. Cancer Institutes
17.2.3. Diagnostic Centers
17.2.4. Others
17.3.Market Size (US$ Mn) Forecast By End User, 2017–2027
17.3.1. Hospitals
17.3.2. Cancer Institutes
17.3.3. Diagnostic Centers
17.3.4. Others
17.4.Market Attractiveness Analysis By End User
18. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2016 and Forecast 2017–2027
18.1.Market Size and Y-o-Y Growth
18.2.Absolute $ Opportunity
19. Research Methodology
Exosome Diagnostic And Therapeutics Market Reports - List of Tables
Table 01: North Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 02: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 03: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 04: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 05: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 06: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 07: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 08: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 09: Western Europe Exosome Diagnostic And Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 10: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 11: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 12: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 13: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 14: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 15: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 16: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 17: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 18: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 19: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 20: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 21: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 22: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 23: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 24: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 25: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 26: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 27: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 28: Global Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Region
Table 29: Global Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type
Table 30: Global Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Application
Table 31: Global Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Exosome Diagnostic And Therapeutics Market Reports - List of Figures
Figure 01: Global Exosome Diagnostic and Therapeutics Market Value Share By Product Type (2017 E)
Figure 02: Global Exosome Diagnostic and Therapeutics Market Value Share By Application (2017 E)
Figure 03: Global Exosome Diagnostic and Therapeutics Market Value Share By End User (2017 E)
Figure 04: Global Exosome Diagnostic and Therapeutics Market Value Share By Region (2017 E)
Figure 05: Wheel of Fortune
Figure 06: Role of Exosome in Cell-to-Cell Communication
Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 08: Applications of Exosome
Figure 09: North America Exosome Diagnostics and Therapeutics Market Share, By Product Type (2017)
Figure 10: North America Exosome Diagnostics and Therapeutics Market Share, By Application (2017)
Figure 11: North America Exosome Diagnostics and Therapeutics Market Share, By End User (2017)
Figure 12: North America Exosome Diagnostics and Therapeutics Market Share, By Country (2017)
Figure 13: North America Exosome Diagnostics and Therapeutics Market size (US$ Mn) 2017 & 2027
Figure 14: North Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016,
Figure 15: North Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 16: U.S. Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 17: U.S. Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 18: Canada Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 19: Canada Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 20: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Instruments
Figure 21: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Instruments
Figure 22: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Software
Figure 23: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Software
Figure 24: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Reagents & Kits
Figure 25: North America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Reagents & Kits
Figure 26: North America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, , By Country
Figure 27: North America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 28: North America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 29: North America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 30: Latin America Exosome Diagnostics and Therapeutics Market Share, By Product Type (2017)
Figure 31: Latin America Exosome Diagnostics and Therapeutics Market Share, By Application (2017)
Figure 32: Latin America Exosome Diagnostics and Therapeutics Market Share, By End User (2017)
Figure 33: Latin America Exosome Diagnostics and Therapeutics Market Share, By Country (2017)
Figure 34: Latin America Exosome Diagnostics and Therapeutics Market size (US$ Mn) 2017 & 2027
Figure 35: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016,
Figure 36: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 37: Brazil Exosome Diagnostic And Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 38: Brazil Exosome Diagnostic And Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 39: Mexico Exosome Diagnostic And Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 40: Mexico Exosome Diagnostic And Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 41: Rest of Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 42: Rest of Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 43: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Instruments
Figure 44: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Instruments
Figure 45: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Software
Figure 46: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Software
Figure 47: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Reagents & Kits
Figure 48: Latin America Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Reagents & Kits
Figure 49: Latin America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, , By Country
Figure 50: Latin America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 51: Latin America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 52: Latin America Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 53: Western Europe Exosome Diagnostics and Therapeutics Market Share, By Product Type (2017)
Figure 54: Western Europe Exosome Diagnostics and Therapeutics Market Share, By Application (2017)
Figure 55: Western Europe Exosome Diagnostics and Therapeutics Market Share, By End User (2017)
Figure 56: Western Europe Exosome Diagnostics and Therapeutics Market Share, By Country (2017)
Figure 57: Western Europe Exosome Diagnostics and Therapeutics Market size (US$ Mn) 2017 & 2027
Figure 58: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016,
Figure 59: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 60: U.K Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 61: U.K Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 62: France Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 63: France Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 64: Germany Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 65: Germany Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 66: Italy Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 67: Italy Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 68: Spain Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 69: Spain Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 70: Rest of Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 71: Rest of Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 72: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Instruments
Figure 73: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Instruments
Figure 74: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Software
Figure 75: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Software
Figure 76: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Reagents & Kits
Figure 77: Western Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Reagents & Kits
Figure 78: Western Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, , By Country
Figure 79: Western Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 80: Western Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 81: Western Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 82: Eastern Europe Exosome Diagnostics and Therapeutics Market Share, By Product Type (2017)
Figure 83: Eastern Europe Exosome Diagnostics and Therapeutics Market Share, By Application (2017)
Figure 84: Eastern Europe Exosome Diagnostics and Therapeutics Market Share, By End User (2017)
Figure 85: Eastern Europe Exosome Diagnostics and Therapeutics Market Share, By Country (2017)
Figure 86: Eastern Europe Exosome Diagnostics and Therapeutics Market size (US$ Mn) 2017 & 2027
Figure 87 Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016,
Figure 88: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 89: Russia Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 90: Russia Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 91: Poland Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 92: Poland Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 93: Rest of Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 94: Rest of Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 95: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Instruments
Figure 96: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Instruments
Figure 97: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Software
Figure 98: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Software
Figure 99: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Reagents & Kits
Figure 100: Eastern Europe Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Reagents & Kits
Figure 101: Eastern Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, , By Country
Figure 102: Eastern Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 103: Eastern Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 104: Eastern Europe Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 105: APEJ Exosome Diagnostics and Therapeutics Market Share, By Product Type (2017)
Figure 106: APEJ Exosome Diagnostics and Therapeutics Market Share, By Application (2017)
Figure 107: APEJ Exosome Diagnostics and Therapeutics Market Share, By End User (2017)
Figure 108: APEJ Exosome Diagnostics and Therapeutics Market Share, By Country (2017)
Figure 109: APEJ Exosome Diagnostics and Therapeutics Market size (US$ Mn) 2017 & 2027
Figure 110: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016,
Figure 111: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 112: China Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 113: China Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 114: India Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 115: India Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 116: ASEAN Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 117: ASEAN Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 118: Australia and New Zealand Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 119: Australia and New Zealand Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 120: Rest of APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 121: Rest of APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 122: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Instruments
Figure 123: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Instruments
Figure 124: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Software
Figure 125: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Software
Figure 126: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Reagents & Kits
Figure 127: APEJ Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Reagents & Kits
Figure 128: APEJ Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, , By Country
Figure 129: APEJ Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 130: APEJ Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 131: APEJ Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 132: Japan Exosome Diagnostics and Therapeutics Market Share, By Product Type (2017)
Figure 133: Japan Exosome Diagnostics and Therapeutics Market Share, By Application (2017)
Figure 134: Japan Exosome Diagnostics and Therapeutics Market Share, By End User (2017)
Figure 135: Japan Exosome Diagnostics and Therapeutics Market size (US$ Mn) 2017 & 2027
Figure 136: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Instruments
Figure 137: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Instruments
Figure 138: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Software
Figure 139: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Software
Figure 140: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Reagents & Kits
Figure 141: Japan Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Reagents & Kits
Figure 142: Japan Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 143: Japan Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 144: Japan Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 145: MEA Exosome Diagnostics and Therapeutics Market Share, By Product Type (2017)
Figure 146: MEA Exosome Diagnostics and Therapeutics Market Share, By Application (2017)
Figure 147: MEA Exosome Diagnostics and Therapeutics Market Share, By End User (2017)
Figure 148: MEA Exosome Diagnostics and Therapeutics Market Share, By Country (2017)
Figure 149: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016,
Figure 150: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 151: GCC Countries Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 152: GCC Countries Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 153: South Africa Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016
Figure 154: South Africa Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 155: Rest of MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Country
Figure 156: Rest of MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 157: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Instruments
Figure 158: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Instruments
Figure 159: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Software
Figure 160: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Software
Figure 161: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) Analysis, 2012–2016, By Reagents & Kits
Figure 162: MEA Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, By Reagents & Kits
Figure 163: MEA Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, , By Country
Figure 164: MEA Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 165: MEA Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 166: MEA Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 167: Exosome Diagnostics Inc. Number of Pipeline Products by Category (2017)
Figure 168: Exosome Diagnostic Inc. Pipeline Analysis By Geography (2017)
Figure 169: Exosome Diagnostics Inc. Number of Pipeline Products by Development Stage (2017)
Figure 170: Exosome Diagnostics Inc. Number of Pipeline Products by Indication (2017
Figure 171: Exiqon AS Pipeline Analysis By Development Status (2017)
Figure 172: Exiqon AS Pipeline Analysis By Indication
Figure 173: Miltenyi Biotec GmbH Pipeline Analysis By Development Status (2017)
Figure 174: Miltenyi Biotec GmbH Pipeline Analysis By Indication
Figure 175: Global Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Region
Figure 176: Global Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Product Type
Figure 177: Global Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By Application
Figure 178: Global Exosome Diagnostic and Therapeutics Market Attractiveness Analysis, By End User
Figure 179: Global Single-Photon Emission Computed Tomography Historical Market Size and Y-o-Y, 2012 - 2016
Figure 180: Global Exosome Diagnostic and Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 181: Global Exosome Diagnostic and Therapeutics Market Absolute $ Opportunity, 2012–2027